stockrow
Friday 6 November 2026
Export STXS’s income statement to Excel — free account
Stereotaxis Inc.
STXS Healthcare Medical Instruments & Supplies
Stereotaxis Inc.’s revenue for fiscal 2025 (year ended December 2025) was $32.4 million, up 20.3% from fiscal 2024.
- Revenue
- −12.8%
- EPS
- 0.00%
- Free cash flow
- +0.45%
Quarter to June 2026, against a year earlier
1.07
0.02
+1.90%
Follow STXS
Alert me
Stereotaxis Inc. (STXS) P/E ratio
Stereotaxis Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 52.5× (October 2017) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 42 more quarters | Free account |
Against its own ten years
Low 0.0×
High 52.5×
Ten-year median
0.0×
Current reading's percentile
98
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| STXS Stereotaxis Inc. | n/m |
| KRMD KORU Medical Systems, Inc. compare | n/m |
| POCI Precision Optics Corp. compare | n/m |
| HBIO Harvard Bioscience, Inc. compare | n/m |
| ZTEKF Zentek Ltd. compare | n/m |
| DXR Daxor Corporation compare | 4.0× |
| PDEX Pro-Dex, Inc. compare | 16.4× |
| UTMD Utah Medical Products, Inc. compare | 21.7× |
| DAVI Davion Healthcare PLC compare | — |
| Medical Instruments & Supplies industry median | 30.3× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)